Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
US Market
Advertisement

Alnylam Pharma (ALNY) Ratios

Compare
1,345 Followers

Alnylam Pharma Ratios

ALNY's free cash flow for Q3 2025 was $0.84. For the 2025 fiscal year, ALNY's free cash flow was decreased by $ and operating cash flow was $0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.54 3.08 3.51 2.41 1.91
Quick Ratio
2.49 2.99 3.34 2.31 1.83
Cash Ratio
0.96 0.84 1.13 0.69 0.44
Solvency Ratio
0.02 -0.10 -0.29 -0.26 -0.34
Operating Cash Flow Ratio
0.17 0.11 -0.70 -0.54 -0.55
Short-Term Operating Cash Flow Coverage
1.66 1.89 -13.43 -17.31 -46.18
Net Current Asset Value
$ -664.96M$ -1.07B$ -1.01B$ -186.32M$ -230.99M
Leverage Ratios
Debt-to-Assets Ratio
0.57 0.70 0.37 0.27 0.15
Debt-to-Equity Ratio
11.86 -12.16 -8.34 1.70 0.51
Debt-to-Capital Ratio
0.92 1.09 1.14 0.63 0.34
Long-Term Debt-to-Capital Ratio
0.91 1.10 1.07 0.76 0.16
Financial Leverage Ratio
20.74 -17.36 -22.41 6.19 3.35
Debt Service Coverage Ratio
0.81 -1.50 -4.74 -3.68 -7.56
Interest Coverage Ratio
1.63 -2.33 -5.03 -4.95 -9.80
Debt to Market Cap
0.04 0.10 0.08 0.09 0.01
Interest Debt Per Share
22.33 22.45 12.13 9.63 5.27
Net Debt to EBITDA
6.88 -7.24 -0.49 -0.27 -0.03
Profitability Margins
Gross Profit Margin
83.99%83.02%83.73%83.40%84.16%
EBIT Margin
4.06%-17.08%-93.60%-83.99%-156.46%
EBITDA Margin
5.81%-14.12%-89.31%-78.36%-149.40%
Operating Profit Margin
8.25%-15.43%-75.68%-83.93%-168.09%
Pretax Profit Margin
-1.00%-23.71%-108.63%-100.93%-173.60%
Net Profit Margin
1.36%-24.08%-109.04%-101.01%-174.15%
Continuous Operations Profit Margin
1.36%-24.08%-109.04%-101.01%-174.15%
Net Income Per EBT
-136.38%101.55%100.37%100.08%100.31%
EBT Per EBIT
-12.07%153.63%143.55%120.25%103.28%
Return on Assets (ROA)
0.90%-11.49%-31.90%-23.41%-25.19%
Return on Equity (ROE)
26.13%199.53%714.91%-144.99%-84.46%
Return on Capital Employed (ROCE)
8.03%-9.86%-28.26%-28.90%-36.35%
Return on Invested Capital (ROIC)
-10.44%-9.69%-27.54%-28.04%-35.68%
Return on Tangible Assets
0.90%-14.06%-34.47%-23.41%-25.19%
Earnings Yield
0.07%-1.84%-3.91%-4.25%-5.74%
Efficiency Ratios
Receivables Turnover
3.33 5.58 4.36 4.25 4.81
Payables Turnover
4.37 5.59 1.72 1.91 1.50
Inventory Turnover
6.82 3.48 1.31 1.14 0.85
Fixed Asset Turnover
4.63 2.52 1.40 1.15 0.70
Asset Turnover
0.66 0.48 0.29 0.23 0.14
Working Capital Turnover Ratio
1.35 0.93 0.58 0.62 0.54
Cash Conversion Cycle
79.73 104.98 150.46 214.18 264.47
Days of Sales Outstanding
109.70 65.44 83.72 85.85 75.85
Days of Inventory Outstanding
53.53 104.82 278.83 319.57 431.64
Days of Payables Outstanding
83.50 65.28 212.09 191.24 243.01
Operating Cycle
163.22 170.26 362.55 405.42 507.48
Cash Flow Ratios
Operating Cash Flow Per Share
2.02 0.83 -4.45 -5.42 -5.35
Free Cash Flow Per Share
1.68 0.34 -5.04 -6.06 -5.96
CapEx Per Share
0.34 0.50 0.59 0.64 0.61
Free Cash Flow to Operating Cash Flow
0.83 0.40 1.13 1.12 1.11
Dividend Paid and CapEx Coverage Ratio
5.97 1.67 -7.51 -8.40 -8.74
Capital Expenditure Coverage Ratio
5.97 1.67 -7.51 -8.40 -8.74
Operating Cash Flow Coverage Ratio
0.10 0.04 -0.41 -0.64 -1.18
Operating Cash Flow to Sales Ratio
0.08 0.06 -0.52 -0.76 -1.25
Free Cash Flow Yield
0.37%0.18%-2.12%-3.57%-4.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
1.37K -54.31 -25.57 -23.55 -17.41
Price-to-Sales (P/S) Ratio
18.68 13.08 27.88 23.79 30.32
Price-to-Book (P/B) Ratio
255.13 -108.36 -182.78 34.15 14.71
Price-to-Free Cash Flow (P/FCF) Ratio
270.94 569.99 -47.15 -27.97 -21.81
Price-to-Operating Cash Flow Ratio
224.45 229.54 -53.43 -31.30 -24.30
Price-to-Earnings Growth (PEG) Ratio
12.17 0.87 -0.88 6.76 2.17
Price-to-Fair Value
255.13 -108.36 -182.78 34.15 14.71
Enterprise Value Multiple
328.38 -99.82 -31.70 -30.63 -20.33
Enterprise Value
61.26B 25.78B 29.37B 20.26B 14.97B
EV to EBITDA
328.38 -99.82 -31.70 -30.63 -20.33
EV to Sales
19.08 14.10 28.31 24.00 30.37
EV to Free Cash Flow
276.73 614.57 -47.89 -28.22 -21.84
EV to Operating Cash Flow
230.41 247.50 -54.27 -31.58 -24.34
Tangible Book Value Per Share
1.78 -7.35 -3.47 4.97 8.84
Shareholders’ Equity Per Share
1.78 -1.77 -1.30 4.97 8.84
Tax and Other Ratios
Effective Tax Rate
2.36 -0.02 >-0.01 >-0.01 >-0.01
Revenue Per Share
24.42 14.64 8.53 7.13 4.29
Net Income Per Share
0.33 -3.52 -9.30 -7.20 -7.46
Tax Burden
-1.36 1.02 1.00 1.00 1.00
Interest Burden
-0.25 1.39 1.16 1.20 1.11
Research & Development to Revenue
0.39 0.55 0.85 0.94 1.33
SG&A to Revenue
0.37 0.44 0.74 0.74 1.19
Stock-Based Compensation to Revenue
0.11 0.12 0.22 0.20 0.28
Income Quality
6.10 -0.24 0.48 0.75 0.72
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis